T Kitamoto
Overview
Explore the profile of T Kitamoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
183
Citations
4099
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakatani E, Kanatani Y, Kaneda H, Nagai Y, Teramukai S, Nishimura T, et al.
Eur J Neurol
. 2016 May;
23(9):1455-62.
PMID: 27222346
Background And Purpose: Akinetic mutism is thought to be an appropriate therapeutic end-point in patients with sporadic Creutzfeldt-Jakob disease (sCJD). However, prognostic factors for akinetic mutism are unclear and clinical...
2.
Saito T, Anazawa T, Gotoh M, Uemoto S, Kenmochi T, Kuroda Y, et al.
Transplant Proc
. 2010 Dec;
42(10):4213-6.
PMID: 21168667
Purpose: The potential for introducing transmissible spongiform encephalopathy (TSE) into islet cells was indicated by recognizing that Liberase HI is isolated from Clostridium histolyticum grown in media containing brain-heart infusion...
3.
Iwasaki Y, Mimuro M, Yoshida M, Kitamoto T, Hashizume Y
Eur J Neurol
. 2010 Aug;
18(7):999-1002.
PMID: 20722706
Background: It is not known whether the clinical course of Japanese sporadic Creutzfeldt-Jakob disease (sCJD) cases differs from that of Caucasian sCJD cases. Patients And Methods: To investigate the clinical...
4.
Saitoh Y, Ogawa M, Naito Y, Komatsuzaki Y, Tagaya H, Arima K, et al.
Neurology
. 2009 Dec;
74(1):86-9.
PMID: 20038778
No abstract available.
5.
Terada T, Tsuboi Y, Obi T, Doh-ura K, Murayama S, Kitamoto T, et al.
Acta Neurol Scand
. 2009 Oct;
121(2):127-30.
PMID: 19804470
Treatment with intraventricular pentosan polysulphate (PPS) might be beneficial in patients with Creutzfeldt-Jakob disease. We report a 68-year-old woman with sporadic Creutzfeldt-Jakob disease who received continuous intraventricular PPS infusion (1-120...
6.
Aldrich B, Frakes E, Kasuya J, Hammond D, Kitamoto T
Neuroscience
. 2009 Aug;
164(2):711-23.
PMID: 19699278
Chronic neuropathic pain caused by peripheral nerve injury is associated with global changes in gene expression in damaged neurons. To understand the molecular mechanisms underlying neuropathic pain, it is essential...
7.
Kasuya J, Kaas G, Kitamoto T
Neuroscience
. 2009 Jul;
163(3):825-37.
PMID: 19619614
Lithium is an efficacious drug for the treatment of mood disorders, and its application is also considered a potential therapy for brain damage. However, the mechanisms underlying lithium's therapeutic action...
8.
Sakai T, Kasuya J, Kitamoto T, Aigaki T
Genes Brain Behav
. 2009 Jun;
8(5):546-57.
PMID: 19531155
Transient receptor potential (TRP) channels play crucial roles in sensory perception. Expression of the Drosophila painless (pain) gene, a homolog of the mammalian TRPA1/ANKTM1 gene, in the peripheral nervous system...
9.
Nakamura N, Aoki Y, Horiuchi H, Furusawa S, Yamanaka H, Kitamoto T, et al.
Cytotechnology
. 2008 Nov;
32(3):191-8.
PMID: 19002980
The chicken is a useful animal for the development of the specificantibodies against the mammalian conserved proteins. We generated twotypes of recombinant chicken monoclonal antibodies (mAbs), using a phagedisplay technique...
10.
Noguchi-Shinohara M, Hamaguchi T, Kitamoto T, Sato T, Nakamura Y, Mizusawa H, et al.
Neurology
. 2007 Jul;
69(4):360-7.
PMID: 17646628
Background: A subset of patients with dura mater graft-associated Creutzfeldt-Jakob disease (dCJD) demonstrates atypical clinical features and plaque formation in the brain (plaque type). Objective: To elucidate the frequency and...